All sites C00-96,D32-33,D42-43,D45-47,D76 605 89.0 2.7 3.2 0.9 4.3
Mouth, pharynx C00-14 12 96.6 - - - 3.4
  Lip C00 2 100.0 - - - -
  Tongue C02 4 100.0 - - - -
  Mouth, other C03-06 2 100.0 - - - -
  Salivary glands C07-08 2 90.9 - - - 9.1
  Pharynx C01,C09-14 2 91.7 - - - 8.3
Digestive organs C15-26 108 79.7 3.0 9.4 1.7 6.3
  Oesophagus C15 5 91.3 4.3 - 4.3 -
  Stomach C16 12 96.6 - 3.4 - -
  Small intestine C17 1 100.0 - - - -
  Colon C18 35 96.6 - 1.1 - 2.3
  Rectum, rectosigmoid C19-20 17 94.0 - 1.2 - 4.8
  Anus C21 1 100.0 - - - -
  Liver C22 6 56.3 - 34.4 - 9.4
  Gallbladder, bile ducts C23-24 7 50.0 8.8 11.8 - 29.4
  Pancreas C25 22 50.9 10.9 23.6 4.5 10.0
  Other digestive organs C26 3 33.3 - 33.3 20.0 13.3
Respiratory organs C30-39 22 80.2 8.1 5.4 1.8 4.5
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 1 100.0 - - - -
  Lung, trachea C33-34 20 80.2 8.9 4.0 2.0 5.0
  Mediastinum, pleura C38 0 - - 100.0 - -
Bone C40-41 1 100.0 - - - -
Melanoma of the skin C43 25 100.0 - - - -
Skin, non-melanoma C44 44 100.0 - - - -
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 4 95.0 - - - 5.0
Breast C50 184 99.1 0.1 0.1 0.3 0.3
Female genital organs C51-58 72 93.9 1.4 2.5 0.3 1.9
  Cervix uteri C53 5 96.3 - - 3.7 -
  Corpus uteri C54 40 99.5 - 0.5 - -
  Uterus, other C55,C58 - - - - - -
  Ovary C56 19 82.1 5.3 7.4 - 5.3
  Other female genital C51-52,C57 8 92.1 - 2.6 - 5.3
Urinary organs C64-68 27 85.8 - 3.7 1.5 9.0
  Kidney C64 15 78.9 - 6.6 1.3 13.2
  Bladder and urinary tract2 C65-68 12 94.8 - - 1.7 3.4
Eye C69 0 - - - 100.0 -
Brain, central nervous system C70-72,D32-33,D42-43 19 81.1 - 4.2 - 14.7
Thyroid gland C73 14 98.5 - - - 1.5
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 17 51.8 8.2 18.8 2.4 18.8
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 56 68.3 15.3 2.1 2.1 12.1
  Hodgkin lymphoma C81 2 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 22 96.4 0.9 - 0.9 1.8
  Malignant immunoproliferative diseases C88 2 87.5 - - - 12.5
  Myeloma and other plasma cell tumors C90 7 37.1 11.4 14.3 5.7 31.4
  Leukaemia C91-95 11 58.9 30.4 - 1.8 8.9
  Myelodysplastic syndromes D46 4 14.3 33.3 4.8 4.8 42.9
  Myeloproliferaitive neoplasms D45,D47 8 44.7 36.8 - 2.6 15.8
Not included above
  Carcinoma in situ of the breast D05 9 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 37 100.0 - - - -
  Borderline tumour of the ovary D39 6 100.0 - - - -
  Basal cell carcinoma of the skin 63 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.